文献库搜索 | GeneLibs

Wu(T),Lv(B),Wang(H),He(G),Fu(Y),Ji(X),Zeng... Bioact Mater 2027-01-00

...cancer (CC), yet their efficacy is limited to a subset of patients owing to low tumor immunogenicity. Single-cell RNA se...

Shamoto(T),Yamamoto(H),Naito(T),Yamada(M),... DEN Open 2027-04-00

...cancer. However, reports of gastric cancer diagnosed at an early stage and treated endoscopically during long-term follo...

Lin(X),Murchú(MÓ),Sheridan(L),Menon(S),Han... Clin Transl Radiat Oncol 2027-01-00

...cancer hallmarks, including sustained proliferative signalling, angiogenesis, metabolic reprogramming, immune evasion, i...

Dinh(T),Lee(J),Islam(S),Nanda(N),Bjelivuk(... Genes Dis 2027-01-00

...cancer immunotherapy. However, therapeutic strategies to induce these structures are currently limited. We evaluated the...

Liu(Y),Wu(Y),Zhang(H),Bao(R),Wang(J),Chen(... Nanomaterials (Basel) 2026-01-26

...cancer (NSCLC). The hybridization of target molecules with MB could trigger the disruption of FRET and the recovery of f...

Thamizhchelvan(AM),Wells(K),Pham(J),Galhen... Nanomaterials (Basel) 2026-01-27

...cancer immunotherapy. Nano-enabled platforms can reprogram TAMs from a pro-tumorigenic M2-like phenotype to an anti-tumo...

Roibu(A),Iliescu(FS),Zamfirescu(AM),Radu(E... Nanomaterials (Basel) 2026-01-27

...cancer therapy, wound healing, and tissue regeneration. Moreover, we present relevant design considerations, performance...

Geeraerts(J),Pivodic(L),Nooijer(K),Rosquin... Palliat Med 2026-04-00

People with advanced cancer often experience a range of symptoms and reduced well-being. Experience sampling methods, wh...

Kouki(O),Lasram(MM),Abidi(A),Leprince(J),G... Cells 2026-01-23

...cancer remains one of the leading causes of cancer-related mortality among women worldwide. Although cisplatin is widely...

Głowacka(P),Pudlarz(A),Wasiak(J),Peszyńska... Cells 2026-01-24

...cancer agent-ARA12-on astrocytes and cytoprotective action to irradiated normal fibroblast cells. Although GB cells' apo...